[The immunomodulating and metabolic actions of thymalin in an experimental herpetic infection]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|July 1, 1994
PubMed

Insights

Thymalin treatment modulated immune and metabolic responses in mice infected with herpes virus type I. This peptide therapy improved phagocytic activity and normalized metabolic shifts, offering a dual therapeutic effect.

Area of Science:

  • Immunology
  • Virology
  • Biochemistry

Background:

  • Herpes virus type I (HSV-1) infection can cause significant neurological damage.
  • Understanding the immune and metabolic consequences of HSV-1 infection is crucial for developing effective treatments.
  • Investigating immunomodulatory agents like thymalin may offer therapeutic benefits.

Purpose of the Study:

  • To evaluate the effects of thymalin on immune cell activity and metabolic parameters in mice with experimental HSV-1 infection.
  • To assess the immunomodulating and metabolic effects of thymalin treatment.

Main Methods:

  • Intracerebral inoculation of herpes virus type I into CBA mice.
  • Assessment of phagocytic activity of peritoneal macrophages and leukocyte migration.
  • Measurement of enzyme activity in gluconeogenesis and lipid peroxidation in liver tissue.
  • Analysis of blood glucose and glycosylated hemoglobin levels.
  • Histological examination of brain and internal organs.
  • Comparison between thymalin-treated and untreated groups.

Main Results:

  • HSV-1 infection led to suppressed phagocytic activity and reduced leukocyte response to phytohemagglutinin (PHA).
  • Metabolic disturbances, including shifts in gluconeogenesis and lipid peroxidation in liver tissue, were observed.
  • Thymalin treatment demonstrated a combined immunomodulating effect by enhancing phagocytic activity and leukocyte response.
  • Thymalin also exhibited a metabolic effect, counteracting some of the infection-induced biochemical alterations.

Conclusions:

  • Thymalin possesses both immunomodulating and metabolic properties beneficial in managing experimental herpes virus type I infection.
  • The findings suggest thymalin as a potential therapeutic agent for infections involving immune and metabolic dysregulation.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...